Fifteen teams analyzed nearly 500 patients» tumors for genetic aberrations and sequenced the protein - coding DNA of 316 samples — by far the largest
cancer sequencing effort to date.
Large - scale
cancer sequencing efforts such as TCGA and ICGC have catalogued somatic mutations in a variety of common cancer types.
Now comes a second part of the study, something that sets it apart from other
cancer sequencing efforts.
Not exact matches
It will focus its initial clinical
sequencing efforts on
cancer, teaming up with the Moores Cancer Center at the University of California, San Diego to sequence the genomes of every patient who is treated there, as well as perform a full genome sequence on their t
cancer, teaming up with the Moores
Cancer Center at the University of California, San Diego to sequence the genomes of every patient who is treated there, as well as perform a full genome sequence on their t
Cancer Center at the University of California, San Diego to
sequence the genomes of every patient who is treated there, as well as perform a full genome
sequence on their tumors.
The 15 AACR scientists, who were already in Washington, D.C., to meet with the U.S. Food and Drug Administration on genetic testing for
cancer patients, tossed around ideas including expanding NCI's tumor genome -
sequencing efforts and getting the government to cover the costs of genomic tumor profiling.
The convergence of several factors explains the trend: cheaper genetic
sequencing technologies, the discovery of new oncogenes (genes that can cause a normal cell to become cancerous), a new generation of computers and bioinformatics that can analyze vast amounts of data, and a multibillion - dollar
effort by researchers inside and outside the pharma industry to develop targeted drugs and companion diagnostics for
cancer.
It has launched projects such as a major
effort to develop knock - out mice (ScienceNOW, 7 September 2006) and The
Cancer Genome Atlas (Science, 16 December 2005, p. 1751), which, with the cancer institute, is sequencing mutations in human ca
Cancer Genome Atlas (Science, 16 December 2005, p. 1751), which, with the
cancer institute, is sequencing mutations in human ca
cancer institute, is
sequencing mutations in human
cancers.
In 2012, as part of
efforts to better understand the causes of melanoma, researchers at the Broad Institute, the Dana - Farber
Cancer Institute and a number of other institutes reported the results of whole genome
sequencing of 25 human metastatic melanomas (Berger et al., 2012).
Also today, NHGRI and the National
Cancer Institute (NCI), both part of the National Institutes of Health (NIH), announced that all three sequencing centers will devote a significant part of their efforts to The Cancer Genome Atlas (TCGA) Pilot Project, which is testing the feasibility of a large - scale, systematic approach to identify important genomic changes involved in c
Cancer Institute (NCI), both part of the National Institutes of Health (NIH), announced that all three
sequencing centers will devote a significant part of their
efforts to The
Cancer Genome Atlas (TCGA) Pilot Project, which is testing the feasibility of a large - scale, systematic approach to identify important genomic changes involved in c
Cancer Genome Atlas (TCGA) Pilot Project, which is testing the feasibility of a large - scale, systematic approach to identify important genomic changes involved in
cancercancer.
Thanks to the Segals» gift, the pancreatic -
cancer effort will
sequence the genomes of tumors from up to 225 patients from the University of Chicago Medicine - NorthShore University HealthSystem pancreatic
cancer program over the next three years.
Her translational research
efforts devise
sequencing - based diagnostics, decision - support tools and databases, and the use of genomics to evaluate immunity - related aspects of
cancers.
Large - scale
sequencing efforts like the 1,000 Genomes Project and The
Cancer Genome Atlas now consider BAM the standard format for data exchange.
In it, the authors review bioinformatics approaches for evaluating single - base substitutions in both coding and noncoding regions, with an emphasis on large
cancer resequencing efforts including the Tumor Sequencing Project, the Cancer Genome Atlas (TCGA), and the AML1 cancer g
cancer resequencing
efforts including the Tumor
Sequencing Project, the
Cancer Genome Atlas (TCGA), and the AML1 cancer g
Cancer Genome Atlas (TCGA), and the AML1
cancer g
cancer genome.
Topics that will be explored include: • Cellular and developmental origins of pediatric
cancer • Key findings of pan-
cancer analysis
efforts • Computational pipelines to analyze large - scale
sequencing data • Opportunities for leveraging existing
cancer genomics datasets • Strategies for integrative analysis of germline and somatic variants • Correlation of germline / somatic variation to clinical features such as tumor subtype.
TCGA, launched in 2005, is a comprehensive and coordinated
effort to accelerate the understanding of the molecular basis of
cancer through the application of genome analysis technologies, including large - scale genome
sequencing.
The
Sequencing and ncRNA Program (ncRNA core), led by Chang - Gong Liu, Ph.D., is a shared resource established in 2009 to support ncRNA
cancer research efforts at MD Anderson Cancer Center and Institutions under the UT s
cancer research
efforts at MD Anderson
Cancer Center and Institutions under the UT s
Cancer Center and Institutions under the UT system.
He directs a Genome Data Analysis Center as part of The
Cancer Genome Atlas (TCGA) project, a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large - scale genome seque
Cancer Genome Atlas (TCGA) project, a comprehensive and coordinated
effort to accelerate our understanding of the molecular basis of
cancer through the application of genome analysis technologies, including large - scale genome seque
cancer through the application of genome analysis technologies, including large - scale genome
sequencing.